Q4 2024 Earnings Call Transcript March 11, 2025 Legend Biotech Corporation beats earnings expectations. Reported EPS is $0.08, expectations were $-0.39. Operator: Good day, and welcome to the Legend ...

Revenue exceeded analyst estimates by 1.9%. Earnings per share (EPS) also surpassed analyst estimates by 32%. Looking ahead, revenue is forecast to grow 27% p.a. on average during the next 3 years ...

HC Wainwright also issued estimates for Legend Biotech’s Q2 2025 earnings at $0.06 EPS, Q3 2025 earnings at ($0.06) EPS and FY2025 earnings at ($0.07) EPS. Get Legend Biotech alerts: ...

and welcome to the Legend Biotech fourth quarter and full year 2024 earnings call. (Operator Instructions) As a reminder, this call may be recorded. I would now like to turn the call over to ...

Legend Biotech shares dipped 0.8% following the earnings release, suggesting a relatively muted market reaction to the results. This article was generated with the support of AI and reviewed by an ...

Good day, and welcome to the Legend Biotech Fourth Quarter and Full-Year 2024 Earnings Call ... and we continue to maintain a strong balance sheet. Thus, we believe we have sufficient capital ...